Fluoxetine treatment

6/1/1999 • Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

admin June 1, 1999

6/1/1999 • Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and...

Notice: ob_end_flush(): Failed to send buffer of zlib output compression (0) in /homepages/24/d109934528/htdocs/icfda/wp-includes/functions.php on line 5581

6/1/1999 • Fluoxetine treatment of depression. Clinical effects, drug concentrations and monoamine metabolites and N-terminally extended substance P in cerebrospinal fluid.

You may have missed

Sad News: One of our Directors for ICFDA, Dr. Lorraine Day

Ep. 419/420 – Tina Griffin/THE COUNTER CULTURE MOM SHOW: Linking SSRI and Homicidal Ideation – Ann Blake-Tracy

John Virapen

A Tribute To Lisa Marie Presley: Gone Too Soon at Age 54. Seems The Whole World is Living the Serotonin Nightmare!

BOTTOM LINE: NOTHING IS SAFE OR EFFECTIVE WITH FDA APPROVAL!!!!!

Evidence That Low Serotonin Does Not Cause Depression | Psychology Today